All Curated Mutation Sites in IV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in IV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
HA1
  
HA2
  
M1
  
M2
  
NA
  
NP
  
NS1
  
NS2
  
PA
  
PB1
  
PB2
  

Keyword: Cell line-23671418
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 23671418 D60N
PB2
PB2
Cell line
G
S
L
View
2 23671418 D87N
PB2
PB2
Cell line
G
S
L
View
3 23671418 M410V
PB2
PB2
Cell line
G
S
L
View
4 23671418 M66I
PB2
PB2
Cell line
G
S
L
View
5 23671418 N348S
PB2
PB2
Cell line
G
S
L
View
6 23671418 R251K
PB2
PB2
Cell line
G
S
L
View
7 23671418 R293M
PB2
PB2
Cell line
G
S
L
View
8 23671418 A643V
PB1
PB1
Cell line
G
S
L
View
9 23671418 K691N
PB1
PB1
Cell line
G
S
L
View
10 23671418 R254R
PA
PA
Cell line
G
S
L
View
11 23671418 M239V
NP
NP
Cell line
G
S
L
View
12 23671418 I46F
NA
NA
Cell line
G
S
L
View
13 23671418 M15I
NA
NA
Cell line
G
S
L
View
14 23671418 D21G
M
M
Cell line
G
S
L
View
15 23671418 H214Y
M
M
Cell line
G
S
L
View
16 23671418 I28T
M
M
Cell line
G
S
L
View
17 23671418 P69P
M
M
Cell line
G
S
L
View
18 23671418 K156E
HA1
HA
Cell line
G
S
L
View
19 23671418 L191I
HA1
HA
Cell line
G
S
L
View
20 23671418 L191L
HA1
HA
Cell line
G
S
L
View
21 23671418 Q223R
HA1
HA
Cell line
G
S
L
View
22 23671418 R223R
HA1
HA
Cell line
G
S
L
View
23 23671418 D14E
HA
HA
Cell line
G
S
L
View
24 23671418 D187E
HA
HA
Cell line
G
S
L
View
25 23671418 D187N
HA
HA
Cell line
G
S
L
View
26 23671418 D187V
HA
HA
Cell line
G
S
L
View
27 23671418 G131S
HA
HA
Cell line
G
S
L
View
28 23671418 G155E
HA
HA
Cell line
G
S
L
View
29 23671418 I321V
HA
HA
Cell line
G
S
L
View
30 23671418 K142N
HA
HA
Cell line
G
S
L
View
31 23671418 K153E
HA
HA
Cell line
G
S
L
View
32 23671418 K154E
HA
HA
Cell line
G
S
L
View
33 23671418 K154N
HA
HA
Cell line
G
S
L
View
34 23671418 N125D
HA
HA
Cell line
G
S
L
View
35 23671418 N125S
HA
HA
Cell line
G
S
L
View
36 23671418 N156D
HA
HA
Cell line
G
S
L
View
37 23671418 N156E
HA
HA
Cell line
G
S
L
View
38 23671418 N156K
HA
HA
Cell line
G
S
L
View
39 23671418 N156N
HA
HA
Cell line
G
S
L
View
40 23671418 N159K
HA
HA
Cell line
G
S
L
View
41 23671418 N173K
HA
HA
Cell line
G
S
L
View
42 23671418 N38N
HA
HA
Cell line
G
S
L
View
43 23671418 N38S
HA
HA
Cell line
G
S
L
View
44 23671418 P83S
HA
HA
Cell line
G
S
L
View
45 23671418 R223Q
HA
HA
Cell line
G
S
L
View
46 23671418 S183P
HA
HA
Cell line
G
S
L
View
47 23671418 S203T
HA
HA
Cell line
G
S
L
View
48 23671418 T209K
HA
HA
Cell line
G
S
L
View
Contents
Description

The table shows all curated mutation sites of IV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.